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Abstract
Objective: Despite advances in medical care, survival to discharge and full neurological
recovery after cardiac arrest remains < 20% following CPR. An alternate approach to traditional
CPR is extracorporeal cardiopulmonary resuscitation (E-CPR), which places patients on ECMO
during CPR, and provides immediate cardiopulmonary support when traditional resuscitation has
been unsuccessful. Here, we report results from E-CPR at our institution.
Methods: Between 2010 and June 2014, a total of 107 adult ECMO procedures were performed
at our institution. Patient demographics, survival to discharge, and neurological recovery of
patients that underwent E-CPR were retrospectively analyzed with IRB approval.
Results: 23 patients (15 males and 8 females, mean age 46 ± 12 years) underwent E-CPR. All
patients who met criteria were placed on 24-hour hypothermia protocol (target temperature 33
0

C) with initiation of ECMO. The mean duration of ECMO support was 6.2 ± 5.5 days. Nine

patients died while on ECMO from the following causes: anoxic brain injury (4), stroke (4), and
bowel necrosis (1). Two patients with anoxic brain injury on E-CPR donated multiple organs for
transplant. The survival to discharge rate was 30% (7/23 patients) with ~100% full neurological
recovery.
Conclusions: The E-CPR procedure provided reasonable patient recovery. E-CPR also
allowed for neurological recovery and made multi-organ procurement possible. Based on the
above survival rates, E-CPR should be considered when determining the optimal treatment path
for patients who need cardiopulmonary resuscitation. The proper use of E-CPR improved
hospital outcomes for the in-hospital cardiac arrested patients.
Word Count: 240/250
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Title: Saving Life and Brain with Extracorporeal Cardiopulmonary Resuscitation (E-CPR). A
Single Center Analysis of In-Hospital Cardiac Arrests.

Central Message: E-CPR offers means of resuscitation for patients refractory to traditional
CPR. E-CPR improved hospital outcomes for patients who suffered an in-hospital cardiac arrest.

Perspective: Results from E-CPR at our institution show a ~30% hospital discharge rate with no
major neurological consequence. E-CPR also made multi organ procurement possible in nonsurvivors through ECMO support of end-organ function. Based on these statistics, E-CPR
should be considered when determining a treatment path for patients who suffer an in-hospital
cardiac arrest.
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List of abbreviations
ALT: alanine aminotransferase.
AMI: acute myocardial infarction.
APACHE II: acute physiology and chronic health evaluation II.
AST: aspartate aminotransferase.
CPR: cardiopulmonary resuscitation.
ECMO: extracorporeal membrane oxygenation.
ICU: intensive care unit.
E-CPR: extracorporeal cardiopulmonary resuscitation.
MELD: model for end-stage liver disease.
SAPS II: simplified acute physiology score II.
SOFA: sequential organ failure assessment score.
VTach/VFib: ventricular tachycardia or ventricular fibrillation.
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Introduction
Cardiopulmonary resuscitation (CPR) is a widely known procedure used to save lives
when patients undergo cardiac arrest. However, despite being extensively taught and used, CPR
remains ineffective. A meta-analysis has shown that 23.8% of out-of-hospital CPR patients
survive to admission, and a mere 7.6% of these patients ultimately survive to be discharged from
the hospital [1]. Even when CPR takes place in hospital setting, the overall survival rates are not
encouraging. It is reported that <50% of patients survive CPR [2-4], while < 20% of patients
survive to discharge [2, 4]. These results suggest that when traditional CPR is not effective,
alternate means of resuscitation are necessary.
As ECMO rises in popularity and use, there has been increasing interest in its viability
and success when used during CPR (E-CPR). E-CPR provides a method to stabilize
hemodynamics and provide end-organ perfusion when traditional CPR is inadequate and the
cause of cardiac arrest is reversible. While many studies have assessed the efficacy of E-CPR in
pediatric populations [5-7], fewer have investigated it in an adult population. The studies of
adult populations have assessed the success of E-CPR in adult populations by mortality, and
many have not taken end-organ function into account.
In a study that assessed the survival benefits of E-CPR compared to conventional CPR
after a witnessed arrest, E-CPR provided a significantly higher return of spontaneous circulation,
and a ~ 20% increase in survival rate at discharge [8]. Further studies on E-CPR have shown an
increased rate of survival at 1-year [8], and 2-years [9] after discharge when compared to
conventional CPR. Many of these studies on adult E-CPR have taken place under optimal
conditions in institutions that have designated teams of E-CPR specialists, ready to cannulate
patients as a part of the Code Team [8-10].
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Through this investigation, there will be greater understanding of the benefits to be
gained from E-CPR, such as successful hospital discharge with limited neurological damage, or
organ procurement in non-survivors. If shown to be effective, this study will assert that E-CPR
should be considered during in-hospital cardiac arrests.
Methods
From June 2010 through July 2014 a total of 107 adult ECMO procedures were done at
our institution. Of those 107 procedures, 23 patients had E-CPR after failing to respond to
traditional CPR. All E-CPR candidates were in-patients with a witnessed arrest, and the ECMO
team was notified less than 20 minutes following the initial arrest. Our institution’s E-CPR
protocol was applied to all patients as follows; the attending physician in charge of a Code Blue
determined whether ECMO was feasible within 20 minutes of unsuccessful resuscitation based
on the exclusion criteria: patient’s age > 70 years old; the presence of a patient’s ‘Do Not
Resuscitate’ orders; whether the patient has an uncorrectable baseline disease such as terminal
cancer, advanced coronary artery disease, or a previous neurological deficit; if the patient has
uncontrolled sepsis or bleeding. The code team notified the attending physician on call in the
surgical cardiovascular ICU, who immediately evaluated the patient’s risks and benefits. If all
parties were in agreement that ECMO was necessary, the patient was cannulated at the bedside.
Perfusionists were called in to set up the ECMO circuit. CPR was continued until ECMO was
initiated; all E-CPR patients were started on veno-arterial ECMO. The cannulation procedure
was followed as outlined by Lamb and colleagues in order to minimize the risk of excessive
bleeding and limb ischemia [11]. Patients who underwent CPR, but no longer required CPR
during ECMO cannulation were excluded from this study. In house attending intensivists from
the surgical cardiovascular ICU (cardiothoracic surgeons) were responsible for ECMO
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placement in all patients. Their coverage spanned all regular daytime working hours, and 4/7
nights with a nocturnist intensivist. Perfusionists were responsible for ECMO circuit setup, and
were available in-house during all regular daytime hours. Perfusionsists were also on call during
off-hours.
In our institution, 100% of the patients treated with E-CPR were placed on a standard
hypothermia protocol at 33 oC for 24 hours to enhance neurological protection. Target
temperature management was met in all patients via an Artic Sun cooling machine. Clinical
neurological assessment was continued with both cooling and rewarming phases. If a patient had
a focal neurological deficit, uncontrolled seizures, or cerebral oximetry desaturation, the patient
was sent for a CT scan immediately—regardless of whether the patient was on or off ECMO.
Once rewarmed, any persistent coma or neurological deficit necessitated a CT scan. Following a
positive CT scan for suspected anoxic brain injury, neurology was consulted to evaluate
neurological outcomes, and if necessary, a cerebral perfusion scan was performed on ECMO to
diagnose potential brain death. If the patient was deemed to be non-recoverable, terminal ECMO
decannulation was performed after consultations with the family, palliative care team, and the
organ procurement agency.
Patient demographics, E-CPR survival, survival to discharge, and organ and neurological
recovery were retrospectively analyzed through an Institutional Review Board approved database
(Thomas Jefferson University approval #10D.155). The acute physiology and chronic health
evaluation II (APACHE II) [12], model for end stage liver disease (MELD) [13], simplified
acute physiology score II (SAPS II) [14], and sequential organ failure assessment (SOFA) [15]
scores were calculated based on the pre-ECMO, peri-ECMO and post-ECMO data.
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Statistical analyses were performed using Chi-square or Fisher’s exact tests for
categorical variables and Student’s t-tests for continuous variables, as appropriate, to identify the
risk factors for ECMO death. Similar analyses were performed to identify the risk factors for
hospital death among the ECMO survivors. Our sample size was too small for a multivariate
analysis. The results were expressed as number with percentage, or mean ± standard deviation.
P-values < .05 were considered to be significant.
Results
Patients: The 23 patients who received E-CPR at our institution consisted of 15 males and 8
females with a mean age of 46 ± 12 years. The primary diagnoses leading to E-CPR in the
patients were acute myocardial infraction (AMI) (n=9), non-ischemic malignant ventricular
tachy-arrhythmia (n=5), myocarditis (n=2), acute pulmonary embolus (n=2), hypothermia (n=2),
acute rejection (n=1), drug induced cardiac arrest (n=1), and post-cardiotomy failure (n=1). The
initial cardiac rhythms in E-CPR patients were ventricular tachycardia or fibrillation (n=8) or
pulseless electrical activity (n=15). All patients with a ventricular tachyarrhythmia received
electrical defibrillation or cardioversion as appropriate; however, all 8 patients deteriorated into
pulseless electrical activity or cardiac arrest prior to the establishment of ECMO. E-CPR was
performed in the intensive care unit (ICU) (n=9), catheterization lab (n=7), emergency
department (n=5), and operating room (n=2). Of the patients who had an AMI, 2 patients had a
percutaneous coronary intervention (PCI) prior to ECMO. The average time of CPR prior to
ECMO was 54 ± 30 min. With the exception of 2 patients, all underwent femoral cannulation as
described previously. The remaining patients had an open sternum and were cannulated centrally
between the aorta and the right atrium.
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ECMO survival: Following E-CPR, the average time on ECMO was 6.2 ± 5.5 days. 14 patients
(61%) survived ECMO and 9 patients (39%) died while on ECMO (Figure 1). The causes of
death in patients who died on ECMO were anoxic brain injury (n=4), stroke (n=4), and bowel
necrosis (n=1). Among the patients who suffered an anoxic brain injury, 2 donated multiple
organs for transplant. Among the 14 ECMO survivors, 13 had unchanged or improved status in
at least one organ (liver function improved or unchanged in 13, kidney function improved or
unchanged in 13, and lactate improved in 12, unchanged in 1 as shown in Table 1). Acute renal
failure occurred during ECMO in 5 patients. All 5 of these patients were managed by CVVHD
during ECMO treatment. Among the patients who survived ECMO, two were post-cardiotomy
failure status post coronary artery bypass graft. Of the variables tested pertaining to patient
demographics, clinical risk factors, and pre-ECMO laboratory data, only pre-ECMO creatinine
levels (p=0.022), and pre-ECMO pH (p=0.039) correlated with ECMO survival (Table 2). No
verified ICU or disease-specific risk scores pre-ECMO had a correlation with E-CPR survival
(Table 2). On ECMO, cardiac (myocardial standstill, [p=0.034]), and any neurological
complications (stroke and anoxic brain injury) (p=0.001) were factors correlated with death
during ECMO (Table 3). Of the risk scores calculated with data from 24 hours after ECMO
initiation, the MELD, SOFA, and APACHE II scores were correlated with ECMO survival after
E-CPR (Table 4). Isolated data from 24 hours after ECMO initiation associated with ECMO
survival included: lactate levels (survivors: 3.7 ± 2.5; non survivors: 8.8 ± 5.3; p=0.015),
bicarbonate levels (survivors: 27.1 ± 2.7; non survivors: 22.6 ± 1.3; p= 0.0001), and creatinine
levels (survivors: 1.3 ± 0.5; non survivors: 1.9 ± 0.5; p= 0.007).
Hospital Survival: Seven of the 14 patients (50%) who survived ECMO were successfully
discharged from the hospital, yielding a hospital survival rate of 30% (7/23) (Figure 1). The
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causes of death in the seven patients who died following successful ECMO decannulation were
anoxic brain injury post cardiac arrest despite cooling and ECMO (n=2), stroke (n=1), brain
death from unknown reason (n=2), sepsis (n=1), and AMI from the non-revascularized coronary
artery (n=1). All causes of death appeared to be related to the initial insult leading to cardiac
arrest. Of the variables tested pertaining to patient demographics, clinical risk factors, preECMO laboratory data and/or disease-specific risk scores, only pre-ECMO bilirubin levels were
correlated with hospital survival (p=0.040) (Table 5). No pre-ECMO ICU or disease-specific
risk scores were found to correlate with hospital survival after E-CPR. Risk scores taken 24
hours after the initiation of ECMO were not found to have a significant correlation with hospital
survival after E-CPR. The only isolated data from 24 hours after ECMO initiation associated
with hospital survival was 24-hour PaO2 (survivors: 197 ± 115; non survivors: 248 ± 110;
p=0.037) which had an association with hospital survival. 1 patient who developed acute renal
failure survived ECMO but died before discharge. The overall length of the hospital stay after ECPR was 43 ± 28 days. All patients who were discharged from the hospital did not demonstrate
any gross neurological deficits during a follow up visit 4-6 weeks following discharge from a
rehabilitation facility. No patients discharged from the hospital were bed-ridden. There were no
limitations of daily activity at 6-8 week follow-ups from the date of discharge.
Discussion
CPR is a technique used around the world to allow patients a second chance at life.
When traditional CPR fails in a hospital setting, there are alternative procedures for resuscitation.
With the popularity of ECMO growing, and the number of ECMO trained individuals increasing,
E-CPR can provide a method by which a patient can be resuscitated when traditional CPR is
ineffective.
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The present study assesses the survival rate, neurological recovery and end organ
function of E-CPR patients in our institution, while attempting to identify risk factors for patients
undergoing E-CPR. When compared to previously published CPR survival rates (<20%), our ECPR survival rate demonstrated reasonable recovery for arrested patients [2, 4].
Technical issues of cannulation during E-CPR remain an issue that has been discussed in
the literature. A previous study showed an ischemia complication rate of 30% [27]. However,
using our E-CPR technique, including standard peripheral cannulation and the use of distal
profusion catheters in all patients, the risk of lower leg ischemia complications has been lowered
dramatically.
Our study supports a number of findings from an E-CPR study done in pediatric patients,
which demonstrated that patient demographic factors such as age, weight and sex do not effect
survival [6], and another paper indicating a correlation with duration of ECMO [16]. Our study
also partially agrees with major conclusions from previous studies of adult E-CPR patients,
which indicate that a state of acidosis is correlated with poor E-CPR outcomes [20]. However,
our results contradicted the findings of a number of other studies, including those which claimed
that low inotrope levels, low pre-ECMO lactate levels, shorter CPR duration, and low preECMO SOFA scores were associated with favorable outcomes in E-CPR patients [17-19]. We
found no association between any pre-ECMO risk scores (MELD, SAPS II, SOFA, APACHE II)
and ECMO survival. Different from previous reports, the current study investigated end-organ
function to determine if ECMO allowed a patient’s vital organs to remain in functional
condition. Many prior studies have not completed a similar examination.
Interestingly, some of the strongest correlations found in the present study relate to values
taken 24 hours after the initiation of ECMO. The MELD, SOFA and APACHE II scores taken at

13
this time point significantly predicted ECMO survival, with a higher score yielding a worse
prognosis. Knowing this, along with completing a neurological evaluation, provides clinicians
with a benchmark to form a prognosis of whether the patient will survive ECMO following ECPR. Rather than having to wait a number of days, by calculating MELD, SOFA and APACHE
II scores 24 hours after E-CPR, physicians and families can gain better insight into the ultimate
chances the patient has at survival.
Neurological complications remain a major cause of patient death. Although one patient
who developed a stroke during ECMO survived ECMO, the majority of patients who suffered
from anoxic brain injuries or strokes during ECMO developed clinical brain death. Despite the
nature of ECMO, and the hypothermia protocols initiated, we found that 8 patients (35%) had
clinical brain death while on ECMO, and an additional four patients (17%) had major
neurological events after ECMO removal, thus limiting their survival. The timing and causative
factors for the neurological events were unclear, and neurological protection remains important
in improving the survival after E-CPR. That being said, the neurological recovery among
hospital survivors was encouraging. All of the hospital survivors in our study were successfully
discharged without any gross neurological deficits. ECMO treatment has been associated with
the risk of neurological complications, with E-CPR raising that risk even further [21-22]. Prior
studies have compared the efficacy of E-CPR to conventional CPR in preventing long-term
neurological damage, and have shown that E-CPR is significantly better at neurological
protection than conventional CPR [9]. Recently, a single center observational study assessing
the use of aggressive E-CPR combined with hypothermia for cardiac arrest patients demonstrated
similar results of full neurological recovery for the E-CPR survivors [28].
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Organ preservation is another benefit of ECMO treatment. In all but one of the E-CPR
survivors, organ function was either improved or unchanged (Table 1). This is a phenomenon
that has previously been associated with beneficial outcomes from ECMO treatment [23].
Furthermore, in two patients who did not survive ECMO and died of anoxic brain injury, solid
organs were harvested for transplantation. The procurement and sustained function of organs
from ECMO non-survivors is a distinct benefit to be gained from ECMO, as reported previously
by our group and others [24-26]. Results from our current study demonstrated the efficacy of ECPR in also allowing organs to be harvested for transplantation in patients who have suffered an
anoxic brain injury. Organ procurement is clearly a topic that has many potential ethical
implications, though, and this study does not thoroughly investigate the boundaries that
physicians should adhere to when attempting to procure an organ for transplant.
This study was limited due to its retrospective nature, and small sample size. Many
patients who received CPR at our institution during the study period were not candidates for
ECMO due to their age, various comorbidities, and access to ECMO circuits. In the present
setting at our institution, the ECMO team is not a regular part of the Code Team. This leads to
limitations as to when E-CPR can be performed due to variable availability of attending
physicians, perfusionists and ECMO circuits. This is a setting that differs from that described in
a number of previous reports on E-CPR [8-10]. Ideally, our E-CPR sample could have been
compared to an internal control group, but our hospital CPR records are incompletely
documented, and the CPR patient population differed from ours. While there were nearly 450
Code Blues at our institution during this time period, only 23 patients were given E-CPR. This
may have led to bias as to who was treated with E-CPR rather than conventional CPR.
Conclusion
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E-CPR provides a viable alternative to traditional CPR for patients refractory to
conventional resuscitation measures. E-CPR should be strongly considered when the materials
and personnel are available, and patients are unresponsive to conventional CPR. The proper use
of E-CPR may greatly improve hospital outcomes for patients who suffer an in-hospital cardiac
arrest.
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Table 1: Organ function before and after ECMO (ECPR Survivors)

Creatinine (mg/dl)
AST (IU/L)
Lactate (mmol/L)
Murray score

Pre-ECMO
1.1 ± 0.4
147 ± 177
7.0 ± 5.4
2±1

Post-ECMO
1.1 ± 0.3
133 ± 178
2.1 ± 1.5
1±1
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Table 2: Patient demographics, clinical risk factors, laboratory data, and risk scores before ECPR, comparing ECMO survivors to ECMO non-survivors.

Pre ECMO demographics
Age (yr.)
Male gender
Body weight (kg)
Body surface area (m2)
Body mass index (kg/m2)
Clinical risk factors
Smoking history
Coronary artery disease
Diabetes
Laboratory data
White blood cell count (B/L)
Hemoglobin (g/dl)
Platelet count (B/L)
PaO2 (mm Hg)
PaCO2 (mm Hg)
HCO3 (mmol/L)
Creatinine (g/dl)
Bilirubin (mg/dl)
AST (IU/L)
ALT (IU/L)
Lactate (mmol/L)
pH
CPR time before ECMO (min)
Initial rhythm: VAC/VFib
Pre-ECMO Scores
Pre-ECMO MELD
Pre-ECMO SAPS II
Pre-ECMO SOFA
Pre-ECMO APACHE II

ECMO Survivors
N=14

ECMO Non-Survivors
N=9

p

46 ± 10
9 (64%)
84 ± 22
1.96 ± 0.27
28 ± 6.2

45 ± 16
6 (67%)
88 ± 19
2.02 ± 0.25
29 ± 4.5

0.881
0.907
0.637
0.592
0.712

5 (36%)
5 (36%)
2 (14%)

3 (33%)
4 (44%)
4 (44%)

0.907
0.675
0.108

13.8 ± 8.3
11.5 ± 3.4
206 ± 125.4
164 ± 144
45 ± 13
19 ± 5.8
1.1 ± 0.4
0.9 ± 0.8
147 ± 177
95 ± 108
7.0 ± 5.4
7.24 ± 0.17
52 ± 28
2 (14%)

12.8 ± 5.9
12.2 ± 3.1
180.4 ± 99.3
147 ± 153
47 ± 17
15 ± 7.1
1.7 ± 0.7
0.7 ± 0.8
595 ± 889
392 ± 588
13.7 ± 9.3
7.05 ± 0.21
57 ± 35
6 (67%)

0.742
0.605
0.129
0.802
0.772
0.217
0.022
0.589
0.213
0.182
0.072
0.039
0.693
0.010

10.0 ± 3.6
61.6 ± 8.1
14.3 ± 1.1
33.1 ± 8.1

17.6 ± 11.6
56.3 ± 20.6
13.5 ± 2.2
35.4 ± 9.2

0.094
0.639
0.388
0.590

18
Table 3: Complications during ECMO.

Time on ECMO support (days)
Any neurological complications
Anoxic brain injury
Stroke
Myocardial stunning
Hemothorax
Massive hemoptysis
Pneumonia
Cannula Site Bleeding
Liver failure
Ischemic bowel
Leg ischemia

ECMO
Survivors
N=14
7.8 ± 6.3
1 (7%)
0
1 (7%)
1 (7%)
2 (14%)
2 (14%)
2 (14%)
5 (36%)
1 (7%)
0
0

ECMO NonSurvivors
N=9
3.6 ± 2.1
8 (89%)
4 (44%)
4 (44%)
4 (44%)
1 (11%)
0
0
2 (22%)
2 (22%)
1 (11%)
0

p
0.033
<0.001
0.006
0.034
0.034
0.825
0.235
0.235
0.493
0.295
0.202
NA
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Table 4: Risk scores 24 hours after E-CPR.

MELD 24hr of ECMO
SAPS II 24hr of ECMO
SOFA 24hr of ECMO
APACHE II 24hr of ECMO

ECMO Survivors
N=14
15.4 ± 4.1
48.1 ± 7.8
11.4 ± 1.9
22.8 ± 4.1

ECMO Non-Survivors
N=9
22.2 ± 6.3
53.0 ± 4.2
14.5 ± 2.7
29.8 ± 6.7

p
0.011
0.285
0.031
0.013

20
Table 5: Patient demographics of ECMO survivors, comparing hospital survivors to hospital
non-survivors.
Hospital Survivors

Pre ECMO demographics
Age (yr.)
Male gender
Body weight (kg)
Body surface area (m2)
Body mass index (kg/m2)
Clinical risk factors
Smoking history
Coronary artery disease
Diabetes
Laboratory data
White blood cell count (B/L)
Hemoglobin (g/dl)
Platelet count (B/L)
PaO2 (mm Hg)
PaCO2 (mm Hg)
HCO3 (mmol/L)
Creatinine (g/dl)
Bilirubin (mg/dl)
AST (IU/L)
ALT (IU/L)
Lactate (mmol/L)
pH
CPR time before ECMO (min)
Initial rhythm: VTach/VFib
Pre ECMO scores
Pre-ECMO MELD
Pre-ECMO SAPS II
Pre-ECMO SOFA
Pre-ECMO APACHE II

N=7

Hospital NonSurvivors
N=7

p

50 ± 8
4 (57%)
87 ± 28
1.97 ± 0.34
30 ± 7.3

43 ± 10
5 (71%)
80 ± 16
1.95 ± 0.20
26 ± 4.9

0.148
0.577
0.604
0.895
0.339

2 (29%)
3 (43%)
2 (29%)

3 (43%)
2 (29%)
0

0.577
0.577
0.127

13.9 ± 10.5
11.4 ± 3.9
218 ± 154.0
129 ± 154
42 ± 14
18 ± 5.9
1.1 ± 0.5
0.2 ± 0.2
45 ± 24
37 ± 22
5.3 ± 4.6
7.25 ± 0.21
56 ± 34
1 (14%)

13.6 ± 6.1
11.5 ± 3.2
194 ± 99.9
198 ± 136
47 ± 14
19 ± 6.1
1.1 ± 0.2
1.3 ± 0.9
207 ± 206
130 ± 127
8.3 ± 6.0
7.23 ± 0.14
44 ± 16
1 (14%)

0.942
0.988
0.735
0.426
0.580
0.776
0.999
0.040
0.132
0.161
0.382
0.842
0.524
1.000

10.6 ± 3.9
53.0 ± 0
14.0 ± 1.0
35.7 ± 9.9

9.8 ± 3.5
63.8 ± 7.5
14.4 ± 1.1
30.0 ± 4.7

0.789
0.063
0.666
0.237

21
Scores 24hr after ECMO
MELD 24hr of ECMO
SAPS II 24hr of ECMO
SOFA 24hr of ECMO
APACHE II 24hr of ECMO

12.5 ± 4.3
46.3 ± 6.7
11 ± 0
22.0 ± 4.69

17.0 ± 3.1
50.7 ± 9.9
11.5 ± 2.3
23.4 ± 4.0

0.095
0.533
0.607
0.591
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Figure 1. ECMO survival after E-CPR and hospital survival.

ECMO and Hospital Survival Following E-CPR
25

# Patients

20
15

n=2
3

10

n=14
61%

5

n=7
30%

0
Total Number of E-CPR
Patients

ECMO Survivors

Hospital Survivors
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